April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
-
-
November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral renal denervation ...
-
November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of ...
-
November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023 (AHA 2023), which compared the effects of high-sodium and low-sodium ...
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...
July 10, 2024
June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...
June 28, 2024
June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...
June 20, 2024
Study: Young Athletes at Risk for Elevated Blood Pressure Rates, Future Cardiovascular Complications
June 6, 2024 — A substantial portion of young athletes are at risk of hypertension, according to a study presented at ...
June 06, 2024
May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced ...
May 16, 2024
May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...
May 08, 2024
May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...
May 06, 2024
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...
April 07, 2024
April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...
April 01, 2024
March 27, 2024 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI – ...
March 27, 2024
March 27, 2024 — Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug ...
March 27, 2024
March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the ...
March 18, 2024
February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indica ...
February 28, 2024
February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the ...
February 27, 2024
February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or ...
February 14, 2024© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now